CENEXA 05419
CENTRO DE ENDOCRINOLOGIA EXPERIMENTAL Y APLICADA
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Scientific Discussion Session on Type 2 Diabetes. BMS/AstraZeneca
Autor/es:
GAGLIARDINO JJ
Lugar:
Philadelpia
Reunión:
Workshop; Scientific Discussion Session on Type 2 Diabetes; 2012
Institución organizadora:
BMS/AstraZeneca
Resumen:
To review the new data presented on SGLT-2 inhibitors and other anti-diabetic agents during the congress
To seek insights and opinions on the data presented at ADA
To understand how the data presented could impact current and future T2DM clinical practice
To obtain feedback on the new and upcoming treatment options for T2DM, including SGLT-2 inhibitors and their place in the treatment paradigm
